Track topics on Twitter Track topics that are important to you
Grant Thornton LLP has named George Serafin national managing principal of the firm’s Health Care and Life Sciences industry practice. In addition to his new national leadership role overseeing the delivery of audit, tax and consulting services within this industry group, he continues to lead Grant Thornton’s Advisory Services’ Health Care and Life Sciences practice. He succeeds Anne McGeorge, who led Grant Thornton’s Health Care industry practice since 2006.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170810005206/en/
George Serafin (Photo: Business Wire)
Serafin has more than 30 years of experience in the health care and life sciences industries, spanning research and development, engineering, manufacturing, supply chain, quality assurance, regulatory compliance and IT. He works with clients globally to develop and execute business and risk management strategies that promote innovation and growth, operational efficiency and process excellence, and sustained regulatory compliance.
“George’s broad background and ‘molecule to patient’ perspective makes him a natural choice to continue the momentum in our Health Care industry practice,” said Nichole Jordan, national managing partner of Markets, Clients and Industry for Grant Thornton. “His appointment reflects our commitment to our industry program at Grant Thornton, where we’re focused on deeply understanding our clients’ opportunities and challenges and providing insights that help them create, protect and transform value.”
Serafin joined Grant Thornton as a principal in 2017 from Deloitte & Touche LLP, where he led the life sciences and health care regulatory risk and compliance practice. He received a master’s degree in technology management and a bachelor’s degree in biomedical engineering from Stevens Institute of Technology.
About Grant Thornton LLP
Founded in Chicago in 1924, Grant Thornton LLP (Grant Thornton) is the U.S. member firm of Grant Thornton International Ltd, one of the world’s leading organizations of independent audit, tax and advisory firms. Grant Thornton, which has revenues in excess of $1.6 billion and operates 59 offices, works with a broad range of dynamic publicly and privately held companies, government agencies, financial institutions, and civic and religious organizations.
“Grant Thornton” refers to Grant Thornton LLP, the U.S. member firm of Grant Thornton International Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. Services are delivered by the member firms. GTIL and its member firms are not agents of, and do not obligate, one another and are not liable for one another’s acts or omissions. Please see grantthornton.com for further details.
Grant Thornton LLP
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...